Leptin, adiponectin, lipodystrophic and severe insulin resistance syndromes.

Leptin, adiponectin, lipodystrophic and severe insulin resistance syndromes.
Ann Biol Clin (Paris). 2020 May 15;:
Authors: Vatier C, Jéru I, Fellahi S, Capeau J, Bastard JP, Vigouroux C
Abstract
Leptin and adiponectin are two adipokines currently used as biomarkers for diagnostic orientation and phenotyping in syndromes of lipodystrophy and severe insulin resistance. The level of these biomarkers also has an impact on the therapeutic management of the patients. These aspects, as well as our experience as a reference center, are described in this brief overview.
PMID: 32420889 [PubMed - as supplied by publisher]

Source: Annales de Biologie Clinique - May 14, 2020 Category: Biochemistry Authors: Vatier C, Jéru I, Fellahi S, Capeau J, Bastard JP, Vigouroux C Tags: Ann Biol Clin (Paris) Source Type: research